Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 65.52%-12.49M | ---- | -317.87%-36.24M | ---- | -22.82%-8.67M | ---- | 68.51%-7.06M | ---- | 38.69%-22.43M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -165.62%-1.01M | ---- | 62.24%-381K | ---- | -23.50%-1.01M | ---- | 35.26%-817K | ---- | -15.46%-1.26M |
| Interest expense - adjustment | ---- | 104.48%137K | ---- | -87.59%67K | ---- | -53.08%540K | ---- | -8.80%1.15M | ---- | -39.12%1.26M |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | --2.12M | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | -126.39%-1.74M | ---- | 21,913.33%6.6M | ---- | 123.44%30K | ---- | 92.87%-128K | ---- | -269.34%-1.8M |
| -Impairment of trade receivables (reversal) | ---- | -128.29%-1.74M | ---- | 20,440.00%6.16M | ---- | 123.44%30K | ---- | ---128K | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | --442K | ---- | ---- | ---- | ---- | ---- | ---1.8M |
| Revaluation surplus: | ---- | ---- | ---- | -97.81%19K | ---- | 127.22%867K | ---- | ---3.19M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -97.81%19K | ---- | 127.22%867K | ---- | ---3.19M | ---- | ---- |
| Asset sale loss (gain): | ---- | 1,787.14%1.18M | ---- | ---70K | ---- | ---- | ---- | -1,775.00%-3.3M | ---- | -102.47%-176K |
| -Loss (gain) from sale of subsidiary company | ---- | --186K | ---- | ---- | ---- | ---- | ---- | ---100K | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 1,521.43%995K | ---- | ---70K | ---- | ---- | ---- | -1,718.18%-3.2M | ---- | ---176K |
| Depreciation and amortization: | ---- | -13.63%1.71M | ---- | -3.94%1.97M | ---- | -55.06%2.06M | ---- | 16.66%4.57M | ---- | -78.42%3.92M |
| Special items | ---- | -100.43%-18K | ---- | --4.18M | ---- | ---- | ---- | --2.98M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 43.64%-12.24M | ---- | -251.03%-21.73M | ---- | -6.85%-6.19M | ---- | 71.71%-5.79M | ---- | -121.84%-20.48M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -54.03%188K | ---- | 170.88%409K | ---- | -2,785.00%-577K | ---- | ---20K |
| Accounts receivable (increase)decrease | ---- | -10.69%5.09M | ---- | 513.73%5.7M | ---- | 11.39%-1.38M | ---- | -121.52%-1.55M | ---- | -19.32%7.22M |
| Accounts payable increase (decrease) | ---- | 191.66%2.99M | ---- | -749.40%-3.26M | ---- | 110.98%502K | ---- | -149.13%-4.57M | ---- | 8,287.39%9.31M |
| Special items for working capital changes | ---- | 76.45%-130K | ---- | -201.10%-552K | ---- | 382.90%546K | ---- | -152.02%-193K | ---- | 103.66%371K |
| Cash from business operations | ---- | 78.13%-4.3M | ---- | -221.69%-19.65M | ---- | 51.86%-6.11M | ---- | -253.09%-12.69M | ---- | 65.15%-3.59M |
| Other taxs | ---- | ---- | ---- | ---- | ---- | -102.82%-20K | ---- | 521.05%708K | ---- | --114K |
| Special items of business | -971.25%-5.7M | ---- | 102.87%654K | ---- | -5,327.14%-22.79M | ---- | 93.72%-420K | ---- | -5,123.44%-6.69M | ---- |
| Net cash from operations | -971.25%-5.7M | 78.13%-4.3M | 102.87%654K | -220.64%-19.65M | -5,327.14%-22.79M | 48.85%-6.13M | 93.72%-420K | -244.31%-11.98M | -5,123.44%-6.69M | 66.26%-3.48M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 230.77%602K | 165.62%1.01M | 18,100.00%182K | -50.33%381K | -99.69%1K | 41.77%767K | -14.21%320K | -9.83%541K | -57.42%373K | 91.08%600K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | --0 | -2,400.00%-2M | 119.78%8M | -100.69%-80K | 264.00%3.64M | 1,064.00%11.64M | 0.00%1M |
| Sale of fixed assets | ---- | 2,042.86%1.5M | --1.5M | --70K | ---- | ---- | ---- | --6.11M | ---- | ---- |
| Purchase of fixed assets | 80.83%-65K | 88.42%-348K | 88.70%-339K | -525.83%-3M | -525.00%-3M | -11,900.00%-480K | ---480K | 84.62%-4K | ---- | -766.67%-26K |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---962K | ---962K | ---- | ---- | ---- |
| Sale of subsidiaries | 3,726.92%9.95M | --279K | --260K | ---- | ---- | ---- | ---- | --100K | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---16.04M | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | --9.99M | ---- | ---- | --11.86M | ---- | ---- | --2.69M | --2.69M | ---- |
| Cash on investment | ---- | ---- | ---- | -49.31%-19.38M | -311.35%-14.89M | ---12.98M | ---3.62M | ---- | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---132K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 554.21%10.49M | 156.32%12.43M | 106.66%1.6M | -290.10%-22.07M | -399.27%-24.08M | -143.25%-5.66M | -132.79%-4.82M | 730.94%13.08M | 683.90%14.71M | 156.03%1.57M |
| Net cash before financing | 112.18%4.79M | 119.49%8.13M | 104.82%2.26M | -253.98%-41.72M | -794.11%-46.87M | -1,174.38%-11.79M | -165.36%-5.24M | 157.56%1.1M | 358.81%8.02M | 85.48%-1.91M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --400K | ---- | ---- |
| Refund | ---- | ---- | ---- | ---- | ---- | -184.79%-5.41M | ---- | ---1.9M | ---- | ---- |
| Issuing shares | ---- | ---- | ---- | --3.39M | --3.39M | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | -7.02%-61K | -104.48%-137K | -67.65%-57K | 87.59%-67K | 91.92%-34K | 53.08%-540K | 28.89%-421K | 4.40%-1.15M | -7.64%-592K | 17.65%-1.2M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---4K | ---4K | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -63.70%-902K | -160.40%-1.14M | -119.97%-551K | 125.15%1.88M | 361.02%2.76M | -68.11%-7.49M | 28.87%-1.06M | 22.07%-4.46M | 56.81%-1.49M | -250.47%-5.72M |
| Effect of rate | --89K | ---32K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | 127.84%3.89M | 117.55%6.99M | 103.87%1.71M | -106.65%-39.84M | -600.27%-44.11M | -473.89%-19.28M | -196.40%-6.3M | 55.94%-3.36M | 485.94%6.53M | 18.22%-7.62M |
| Begining period cash | 23.14%37.04M | -56.98%30.08M | -56.98%30.08M | -21.61%69.92M | -21.61%69.92M | -3.63%89.19M | -3.63%89.19M | -7.61%92.55M | -7.61%92.55M | -8.51%100.18M |
| Cash at the end | 29.04%41.02M | 23.14%37.04M | 23.17%31.79M | -56.98%30.08M | -68.87%25.81M | -21.61%69.92M | -16.34%82.9M | -3.63%89.19M | 0.61%99.09M | -7.61%92.55M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | 29.04%41.02M | ---- | --31.79M | ---- | ---- | ---- | -16.34%82.9M | ---- | 0.61%99.09M | ---- |
| Cash and cash equivalent balance | 29.04%41.02M | ---- | --31.79M | ---- | ---- | ---- | -16.34%82.9M | ---- | 0.61%99.09M | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants | -- | Hong Kong Lixin Dehao Certified Public Accountants | -- | Hong Kong Lixin Dehao Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.